The presentation, formatted as a fireside chat followed by a question-and-answer period, begins at 10:50 a.m. Eastern Time. Investors and stakeholders can monitor the proceedings via a live webcast hosted on the company’s investor relations portal at ir.QuestDiagnostics.com. For those unable to attend the live broadcast, an archived version will be posted online within 24 hours and will remain accessible until October 13, 2026.
Quest Diagnostics CEO Jim Davis to Outline Strategy at Baird Conference
Jim Davis, the Chairman, CEO, and President of Quest Diagnostics, is scheduled to address investors and industry analysts at the Baird 2026 Global Healthcare Conference. The session will take place in New York City on September 15, where he will detail the firm’s current performance and broader diagnostic market trends.
Quest Diagnostics currently maintains a significant footprint in the American medical landscape, providing diagnostic services to approximately half of the nation's hospitals and physicians. With a workforce of nearly 60,000 employees, the company processes data for one in three American adults annually, positioning its executive commentary as a bellwether for shifts in domestic healthcare management and testing accessibility.
Comments (0)
No comments yet. Be the first!